Search Drug By Letter : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

OXALIPLATIN HOSPIRA

Package(a):
VIALS (powder for solution for infusion): 50 mg.
Dosage(a):
The recommended dose for adjuvant setting is 85 mg/m² IV, repeated every two weeks for 12 cycles (6 months). Dosage should be adjusted according to tolerability. Should always be administered before fluoropyrimidines. See prescribing information for full details.
Prescribing Restrictions:  None

Package(b):
VIALS (powder for solution for infusion): 100 mg.
Dosage(b):
The recommended dose for adjuvant setting is 85 mg/m² IV, repeated every two weeks for 12 cycles (6 months). Dosage should be adjusted according to tolerability. Should always be administered before fluoropyrimidines. See prescribing information for full details.
Prescribing Restrictions:  None


Indications:
In combination with 5-fluorouracil and folinic acid (FA), is indicated for: Adjuvant treatment of stage III (Duke C) colon cancer after complete resection of the primary tumor; treatment of metastic colorectal cancer.
Contra-Indications:
Hypersensitivity to oxaliplatin or to any of the constituents. Myelosuppression prior to starting first course, as evidenced by baseline. Pregnancy and lactation. See prescribing information for full details.
Special Precautions:
Should only be used in specialized departments of oncology and administered under the supervision of an experienced oncologist. See prescribing information for full details.
Side Effects:
See prescribing information for full details.
Drug Interactions:
See prescribing information for full details.